Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02517268 · ClinicalTrials.gov registry record · NA
Accelerated Recovery Pathway for Discharge After Surgery in Patients With Pancreatic Cancer
A NA study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
NCT02517268 is a NA study that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. The registered enrollment target is 98 participants.
The verdict
NCT02517268, a NA study, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
Study Summary
This randomized clinical trial studies accelerated recovery pathway for discharge after surgery in patients with pancreatic cancer. A standardized accelerated recovery pathway may improve outcomes after surgery following complex abdominal operations resulting in a shorter length of stay in patients with pancreatic cancer. It may also help patients to mobilize more quickly and return to the home setting, decrease hospital-acquired infectious complications, and increase potential cost savings. It is not yet known whether an accelerated recovery pathway is better than a standard recovery pathway for discharge following surgery in patients with pancreatic cancer.
Interventions
- PROCEDURE Pancreaticoduodenectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2015-06-24 |
| Est. Completion | 2019-03-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02517268
The ClinicalTrials.gov registry entry for NCT02517268 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pancreaticoduodenectomy is the first listed.
NCT02517268 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02517268 about?
NCT02517268 is a clinical study titled "Accelerated Recovery Pathway for Discharge After Surgery in Patients With Pancreatic Cancer". This randomized clinical trial studies accelerated recovery pathway for discharge after surgery in patients with pancreatic cancer. A standardized accelerated recovery pathway may improve outcomes after surgery following complex abdominal operations resulting in a shorter length of stay in patients ...
What is the current status of trial NCT02517268?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2015-06-24. Estimated completion is 2019-03-28.
What interventions are being tested in trial NCT02517268?
The interventions under investigation include: Pancreaticoduodenectomy (PROCEDURE).
Who is sponsoring clinical trial NCT02517268?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.